肠道微生态与炎性肠病及益生菌的治疗作用

被引：13

作者：

孙川喻

汤庆娅

机构：

[1] 上海交通大学医学院附属新华医院临床营养中心

来源：

临床消化病杂志 | 2014年 / 26卷 / 05期

关键词：

炎性肠疾病; 肠道菌群; 益生菌;

D O I：

暂无

中图分类号：

R574 [肠疾病];

学科分类号：

100201 [内科学];

摘要：

<正>炎性肠病(inflammatory bowel disease,IBD)是一组病因尚不十分明确的慢性非特异性肠道炎性疾病,主要包括克罗恩病(Crohn’s disease,CD)和溃疡性结肠炎(ulcerative colitis,UC)。目前,随着环境和饮食结构的改变、抗生素的广泛使用、社会与心理压力等多种因素的影响,以及诊断技术的提高,IBD的发病率逐年升高。在美国UC和CD的患病

引用

页码：312 / 314

页数：3

共 10 条

[1]

Intestinal microbiota in inflammatory bowel disease: Friend of foe? [J].

Fava, Francesca ;

Danese, Silvio .

WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (05) :557-566

[2]

Nutritional protective mechanisms against gut inflammation [J].

Viladomiu, Monica ;

Hontecillas, Raquel ;

Yuan, Lijuan ;

Lu, Pinyi ;

Bassaganya-Riera, Josep .

JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2013, 24 (06) :929-939

[3]

Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease [J].

Negroni, Anna ;

Costanzo, Manuela ;

Vitali, Roberta ;

Superti, Fabiana ;

Bertuccini, Lucia ;

Tinari, Antonella ;

Minelli, Fabio ;

Di Nardo, Giovanni ;

Nuti, Federica ;

Pierdomenico, Maria ;

Cucchiara, Salvatore ;

Stronati, Laura .

INFLAMMATORY BOWEL DISEASES, 2012, 18 (05) :913-924

[4]

Clinical trial: the microbiological and immunological effects of synbiotic consumption – a randomized double‐blind placebo‐controlled study in active Crohn’s disease.[J].H.Steed;G. T.Macfarlane;K. L.Blackett;B.Bahrami;N.Reynolds;S. V.Walsh;J. H.Cummings;S.Macfarlane.Alimentary Pharmacology & Therapeutics.2010, 7

[5]

A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp . lactis BB-12 for maintenance of remission in ulcerative colitis.[J].Signe Wildt;Inge Nordgaard;Ulla Hansen;Elke Brockmann;Jüri J. Rumessen.Journal of Crohn's and Colitis.2010, 2

[6]

Probiotic Therapy for Ulcerative Colitis [J].

Floch, Martin H. .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (04) :237-238

[7]

A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease [J].

Rahimi, Roja ;

Nikfar, Shekoufeh ;

Rahimi, Fatemeh ;

Elahi, Behzad ;

Derakhshani, Saeed ;

Vafaie, Mohammad ;

Abdollahi, Mohammad .

DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (09) :2524-2531

[8]

High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease [J].

Fujimori, Shunji ;

Tatsuguchi, Atsushi ;

Gudis, Katya ;

Kishida, Teruyuki ;

Mitsui, Keigo ;

Ehara, Akihito ;

Kobayashi, Tsuyoshi ;

Sekita, Yoshihisa .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (08) :1199-1204

[9]

<ce:link locator="fx1"/> The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States.[J].Michael D. Kappelman;Sheryl L. Rifas–Shiman;Ken Kleinman;Dan Ollendorf;Athos Bousvaros;Richard J. Grand;Jonathan A. Finkelstein.Clinical Gastroenterology and Hepatology.2007, 12

[10]

Saccharomyces boulardii in maintenance treatment of Crohn's disease [J].

Guslandi, M ;

Mezzi, G ;

Sorghi, M ;

Testoni, PA .

DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (07) :1462-1464

← 1 →